A detailed history of Casdin Capital, LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 2,000,000 shares of CDXS stock, worth $6.76 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
2,000,000
Previous 2,000,000 -0.0%
Holding current value
$6.76 Million
Previous $6.1 Million 14.43%
% of portfolio
0.56%
Previous 0.64%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.54 - $3.37 $2.62 Million - $5.73 Million
1,700,000 Added 566.67%
2,000,000 $6.1 Million
Q3 2023

Nov 14, 2023

BUY
$1.5 - $3.75 $450,000 - $1.13 Million
300,000 New
300,000 $567,000
Q2 2022

Aug 15, 2022

SELL
$8.35 - $21.89 $2.51 Million - $6.57 Million
-300,000 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$16.97 - $31.93 $68.4 Million - $129 Million
-4,030,000 Reduced 93.07%
300,000 $6.19 Million
Q4 2020

Feb 16, 2021

BUY
$11.7 - $23.41 $4.04 Million - $8.08 Million
345,000 Added 8.66%
4,330,000 $94.5 Million
Q3 2020

Nov 16, 2020

SELL
$11.21 - $13.82 $7.93 Million - $9.78 Million
-707,732 Reduced 15.08%
3,985,000 $46.8 Million
Q2 2020

Aug 14, 2020

SELL
$9.8 - $12.77 $3.73 Million - $4.87 Million
-381,048 Reduced 7.51%
4,692,732 $53.5 Million
Q3 2019

Nov 12, 2019

BUY
$12.75 - $19.01 $64.7 Million - $96.5 Million
5,073,780 New
5,073,780 $67.9 Billion
Q3 2019

Nov 12, 2019

SELL
$12.75 - $19.01 $64.7 Million - $96.5 Million
-5,073,780 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$17.0 - $21.88 $51.8 Million - $66.7 Million
3,048,780 Added 150.56%
5,073,780 $0
Q1 2018

May 15, 2018

BUY
$8.0 - $12.8 $3.4 Million - $5.44 Million
425,000 Added 26.56%
2,025,000 $22.3 Million
Q4 2017

Feb 14, 2018

BUY
$5.85 - $8.4 $731,250 - $1.05 Million
125,000 Added 8.47%
1,600,000 $13.4 Million
Q3 2017

Nov 14, 2017

BUY
$4.9 - $6.65 $7.23 Million - $9.81 Million
1,475,000
1,475,000 $9.81 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $221M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.